טוען...
Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future
Diffuse large B-cell lymphoma (DLBCL) is the most commonly occurring lymphoma in the Western world. DLBCL is a clinically, biologically, and pathologically heterogeneous entity with biologically distinct subtypes that have different expected treatment outcomes. The addition of rituximab to combinati...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3606548/ https://ncbi.nlm.nih.gov/pubmed/23532092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S18701 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|